White House Prescription-Drug Pricing Deals Expand

The White House is announcing nearly a dozen additional pharmaceutical agreements, reportedly bringing the total to 26, plus a GLP-1 Bridge Program. The agreements fit Trump's affordability messaging but have limited disclosed terms, leaving consumer savings, Medicaid effects, implementation, and durability uncertain.